Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Clinical Lung Cancer
|
August 31, 2022
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
Matthew Z Guo, Joseph C Murray, Paola Ghanem, et al.
RMD Open
|
November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Paola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 14, 2023
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report
Dong-Wan Kim, Sang-We Kim, D Ross Camidge, et al.
Bone Marrow Transplantation
|
April 7, 2005
The polymorphisms -318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population
J Svahn, M Capasso, M Lanciotti, et al.
Journal of Neurosurgery
|
June 4, 2021
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy
Pavan P Shah, Jennifer L Franke, Ravi Medikonda, et al.
JAMA Oncology
|
October 29, 2020
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash, et al.
European Review for Medical and Pharmacological Sciences
|
March 18, 2022
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic
R Nevola, A Marrone, D Cozzolino, et al.
Frontiers in Oncology
|
August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
Susan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.
Journal of Oncology Practice
|
August 7, 2019
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes
Aanika Balaji, Jiajia Zhang, Beatriz Wills, et al.
Cancer Research Communications
|
April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer
Michael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Clinical Lung Cancer
|
August 31, 2022
Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
Matthew Z Guo, Joseph C Murray, Paola Ghanem, et al.
RMD Open
|
November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases
Paola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 14, 2023
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report
Dong-Wan Kim, Sang-We Kim, D Ross Camidge, et al.
Bone Marrow Transplantation
|
April 7, 2005
The polymorphisms -318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic anemia in a Caucasian population
J Svahn, M Capasso, M Lanciotti, et al.
Journal of Neurosurgery
|
June 4, 2021
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy
Pavan P Shah, Jennifer L Franke, Ravi Medikonda, et al.
JAMA Oncology
|
October 29, 2020
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash, et al.
European Review for Medical and Pharmacological Sciences
|
March 18, 2022
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic
R Nevola, A Marrone, D Cozzolino, et al.
Frontiers in Oncology
|
August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade
Susan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.
Journal of Oncology Practice
|
August 7, 2019
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes
Aanika Balaji, Jiajia Zhang, Beatriz Wills, et al.
Cancer Research Communications
|
April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung Cancer
Michael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Page
of 11